Financhill
Back

Bolt Biotherapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
48

BOLT
Bolt Biotherapeutics

Last Price:
0.63
Seasonality Move:
-38.25%
Sell
25

NBY
NovaBay Pharmaceuticals

Last Price:
0.50
Seasonality Move:
-14.79%
Sell
48
Bolt Biotherapeutics (BOLT) is a Sell

Is Bolt Biotherapeutics a Buy, Sell or Hold?

  • The current Bolt Biotherapeutics [BOLT] share price is $0.63. The Score for BOLT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • BOLT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.50. The Score for NBY is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BOLT Stock Price Chart

What is Bolt Biotherapeutics's stock price today?

  • The Bolt Biotherapeutics share price today is $0.63
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BOLT is experiencing slight selling pressure.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight selling pressure.

BOLT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 38.19 Sell
Chaikin Money Flow: -41405 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.63 - 0.69) Sell
Bollinger Bands (100): (0.62 - 0.92) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 37.14 Sell
Chaikin Money Flow: -28552 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.47 - 0.53) Sell
Bollinger Bands (100): (0.58 - 3.38) Sell

BOLT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.63 Buy
20-day SMA: 0.65 Sell
50-day SMA: 0.69 Sell
200-day SMA: 0.96 Sell
8-day EMA: 0.63 Sell
20-day EMA: 0.65 Sell
50-day EMA: 0.7 Sell
200-day EMA: 0.92 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.49 Buy
20-day SMA: 0.49 Buy
50-day SMA: 0.86 Sell
200-day SMA: 3.79 Sell
8-day EMA: 0.49 Buy
20-day EMA: 0.53 Sell
50-day EMA: 0.95 Sell
200-day EMA: 8.34 Sell

Bolt Biotherapeutics Earnings Growth & BOLT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.28 per share, and an increase next year of $0.59 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $13.87 per share, an increase next quarter of $0.05 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.

Bolt Biotherapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):